Literature DB >> 10495420

Two distinct regions of deletion on chromosome 13q in primary nasopharyngeal carcinoma.

Y S Tsang1, K W Lo, S F Leung, P H Choi, Y Fong, J C Lee, D P Huang.   

Abstract

Nasopharyngeal carcinoma (NPC) is rare in most parts of the world, but prevalent in Southern China. Although this disease poses a serious health problem in our population, the genetic alterations that lead to the development of NPC have yet to be defined. In a comparative genomic hybridization (CGH) study on NPC by our group, loss of the long arm of chromosome 13 has been identified as a frequent event. To investigate further the involvement of this genetic alteration in NPC tumorigenesis, we examined 31 primary NPC tumours by LOH analysis with a panel of 13 microsatellite polymorphic markers distributed along the long arm of chromosome 13. It was found that 19/31 tumours (60%) showed LOH for markers on chromosome 13q. The highest frequency of LOH was found at loci D13S133 (53.6%) on 13q14.3 and D13S796 (38.5%) on 13q32-34. Two distinct smallest deletion regions were delineated: the first region between D13S133 and D13S119 at 13q14.3-22, and the second region between D13S317 and D13S285 at 13q31-34. Our findings show that LOH of 13q is a common event in NPC and that at least 2 putative tumour-suppressor loci may be present on 13q. Mapping of the critical regions of these loci suggests that some candidate tumour-suppressor genes on 13q, other than Rb and BRCA2, may be involved in the development of NPC. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10495420     DOI: 10.1002/(sici)1097-0215(19991029)83:3<305::aid-ijc3>3.0.co;2-d

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA.

Authors:  Anwar Hossain; Macus T Kuo; Grady F Saunders
Journal:  Mol Cell Biol       Date:  2006-08-28       Impact factor: 4.272

2.  Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus.

Authors:  T Kainu; S H Juo; R Desper; A A Schaffer; E Gillanders; E Rozenblum; D Freas-Lutz; D Weaver; D Stephan; J Bailey-Wilson; O P Kallioniemi; M Tirkkonen; K Syrjäkoski; T Kuukasjärvi; P Koivisto; R Karhu; K Holli; A Arason; G Johannesdottir; J T Bergthorsson; H Johannsdottir; V Egilsson; R B Barkardottir; O Johannsson; K Haraldsson; T Sandberg; E Holmberg; H Grönberg; H Olsson; A Borg; P Vehmanen; H Eerola; P Heikkila; S Pyrhönen; H Nevanlinna
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

3.  Subcellular targeting of p33ING1b by phosphorylation-dependent 14-3-3 binding regulates p21WAF1 expression.

Authors:  Wei Gong; Michael Russell; Keiko Suzuki; Karl Riabowol
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

4.  Restoration of miR17/20a in solid tumor cells enhances the natural killer cell antitumor activity by targeting Mekk2.

Authors:  Hong Jiang; Ping Wang; Xiaohua Li; Qilong Wang; Zhong-Bin Deng; Xiaoying Zhuang; Jingyao Mu; Lifeng Zhang; Baomei Wang; Jun Yan; Donald Miller; Huang-Ge Zhang
Journal:  Cancer Immunol Res       Date:  2014-05-06       Impact factor: 11.151

Review 5.  Locally advanced nasopharyngeal cancer.

Authors:  J F Ensley; E Youssef; H Kim; G Yoo
Journal:  Curr Treat Options Oncol       Date:  2001-02

6.  Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma.

Authors:  Shih-Hsin Chiu; Chung-Chun Wu; Chih-Yeu Fang; Shu-Ling Yu; Hui-Yu Hsu; Yen-Hung Chow; Jen-Yang Chen
Journal:  Oncotarget       Date:  2014-09-30

7.  Prognostic implications of a molecular classifier derived from whole-exome sequencing in nasopharyngeal carcinoma.

Authors:  Hai-Yun Wang; Fugen Li; Na Liu; Xiao-Yun Liu; Xin-Hua Yang; Yun-Miao Guo; Jin-Xin Bei; Yi-Xin Zeng; Jian-Yong Shao
Journal:  Cancer Med       Date:  2019-04-05       Impact factor: 4.452

8.  Investigation of the miR16-1 (C > T) + 7 Substitution in Seven Different Types of Cancer from Three Ethnic Groups.

Authors:  Hulya Yazici; Jennifer Zipprich; Tao Peng; Elif Z Akisik; Hulya Tigli; Mustafa Isin; Ebru E Akisik; Mary Beth Terry; Ruby T Senie; Lequn Li; Minhao Peng; Zhiming Liu; Nejat Dalay; Regina M Santella
Journal:  J Oncol       Date:  2009-10-26       Impact factor: 4.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.